| 000 | 01658 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513075849.0 | ||
| 264 | 0 | _c19930217 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.76.1.8421081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaue, L | |
| 245 | 0 | 0 |
_aTreatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cJan 1993 |
||
| 300 |
_a151-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAge Determination by Skeleton |
| 650 | 0 | 4 | _aBody Height |
| 650 | 0 | 4 |
_aBone Development _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGrowth _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPuberty, Precocious _xblood |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 650 | 0 | 4 |
_aTestolactone _xtherapeutic use |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 650 | 0 | 4 |
_aTriptorelin Pamoate _xanalogs & derivatives |
| 700 | 1 | _aJones, J | |
| 700 | 1 | _aBarnes, K M | |
| 700 | 1 | _aCutler, G B | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 76 _gno. 1 _gp. 151-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.76.1.8421081 _zAvailable from publisher's website |
| 999 |
_c8420352 _d8420352 |
||